Maximum Dose of Symbicort
The maximum recommended dose of Symbicort for adults and adolescents 12 years and older is 160/4.5 mcg, two inhalations twice daily (total daily dose: 640 mcg budesonide/18 mcg formoterol). 1
Standard Dosing Framework
For asthma in patients ≥12 years:
- Starting doses depend on asthma severity:
- Mild to moderate: 80/4.5 mcg, 2 inhalations twice daily
- Moderate to severe: 160/4.5 mcg, 2 inhalations twice daily
- Maximum dose: 160/4.5 mcg, 2 inhalations twice daily (320 mcg per dose, 640 mcg/day total) 1
For COPD:
- Only the 160/4.5 strength is indicated
- Dose: 2 inhalations twice daily 1
For children 6 to <12 years:
- Only 80/4.5 mcg strength: 2 inhalations twice daily 1
Critical Dosing Warnings
More frequent administration or higher number of inhalations than 2 inhalations twice daily is NOT recommended, as patients are more likely to experience adverse effects with higher doses of formoterol 1. This is an explicit FDA warning that should not be exceeded in standard maintenance therapy.
SMART/MART Regimen Exception
When using Symbicort as maintenance and reliever therapy (SMART/MART) - an approach recommended by GINA and NAEPP guidelines for steps 3-4 asthma management 2, 3:
- Maintenance: 160/4.5 mcg, 1-2 inhalations twice daily
- As-needed reliever: Additional 160/4.5 mcg, 1 inhalation as needed for symptoms
- Maximum total daily dose: Up to 12 inhalations in any single day (delivering 54 mcg formoterol total) 3
This SMART approach allows flexible dosing above the standard maximum when used as both controller and reliever, with evidence showing reduced exacerbations compared to fixed-dose regimens 3, 4. However, this specific regimen requires careful patient education and is distinct from standard maintenance therapy.
Important Caveats
- The FDA label maximum (640/18 mcg daily as fixed maintenance) differs from SMART protocols that permit up to 12 inhalations daily when used as maintenance-and-reliever 1, 3
- Patients on Symbicort should never use additional LABA for any reason 1
- A 52-week safety study evaluated doses up to 640/18 mcg twice daily (double the maximum recommended dose) and found a safety profile similar to budesonide alone, though this does not constitute a recommendation for routine use at this level 5